Intravoxel incoherent Motion-derived histogram Metrics for assessment of response after combined chemotherapy and radiation Therapy in rectal cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses1

Radiology

Volumn 280, Issue 2, 2016, Pages 446-454

  Nougaret, Stephanie ^a,b,c   Vargas, Hebert Alberto ^d   Lakhman, Yulia ^d   Sudre, Romain ^e   Do, Richard K G ^d   Bibeau, Frederic ^b,e   Azria, David ^b,e   Assenat, Eric ^e   Molinari, Nicolas ^f   Pierredon, Marie Ange ^a   Rouanet, Philippe ^e   Guiu, Boris ^a,b,c  

^a HÔPITAL SAINT ELOI   (France)

^b INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^c INSERM   (France)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e CENTRE VAL D AURELLE   (France)

^f UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOGRAM; HISTOPATHOLOGY; HUMAN; IMAGING AND DISPLAY; INTERMETHOD COMPARISON; INTRAVOXEL INCOHERENT MOTION IMAGING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; TUMOR VOLUME; VERY ELDERLY; COMBINATION DRUG THERAPY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; DRUG EFFECTS; MIDDLE AGED; MOTION; PROCEDURES; RADIATION RESPONSE; RADIOTHERAPY; RECTAL NEOPLASMS; RECTUM; REPRODUCIBILITY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTION; RADIOTHERAPY; RECTAL NEOPLASMS; RECTUM; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84979868500     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2016150702     Document Type: Article

References (43)

1. Bhangu A, Ali SM, Cunningham D, Brown G, Tekkis P. Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Co-lorectal Dis 2013;15(2):156-163.
2. Habr-Gama A, de Souza PM, Ribeiro U Jr, et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 1998;41(9):1087-1096.
3. Habr-Gama A, Perez RO, Proscurshim I, et al. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum 2008;51(3):277-283.
4. Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Nahas SC, Gama-Rodrigues J. Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey. Tech Coloproctol 2011;15(1):45-51.
5. Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011;29(35):4633-4640.
6. Kosinski L, Habr-Gama A, Ludwig K, Perez R. Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies. CA Cancer J Clin 2012;62(3):173-202.
7. Habr-Gama A, Sabbaga J, Gama-Rodrigues J, et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum 2013;56(10):1109-1117.
8. Habr-Gama A, Gama-Rodrigues J, São Ju-lião GP, et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemora-diation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys 2014;88(4):822-828.
9. Hicks RJ, Ware RE, Lau E W. PET/CT: will it change the way that we use CT in cancer imaging? Cancer Imaging 2006;6:S52-S62.
10. Lambrecht M, Deroose C, Roels S, et al. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol 2010;49(7):956-963.
11. Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roent-genol 2007;188(2):442-451.
12. Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol 2012;19(7):2212-2223.
13. Heald RJ, O'Neill BD, Moran B, et al. MRI in predicting curative resection of rectal cancer: new dilemma in multidisciplinary team management. BMJ 2006;333(7572):808.
14. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001;357 (9255):497-504.
15. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multi-center study. Ann Surg Oncol 2011;18(8): 2224-2231.
16. Jang KM, Kim SH, Choi D, Lee SJ, Park MJ, Min K. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results. Br J Radiol 2012; 85(1017):e566-e572.
17. Song I, Kim SH, Lee SJ, Choi JY, Kim MJ, Rhim H. Value of diffusion-weighted imaging in the detection of viable tumour after neo-adjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol 2012;85(1013):577-586.
18. Genovesi D, Filippone A, Ausili Cèfaro G, et al. Diffusion-weighted magnetic resonance for prediction of response after neoadju-vant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study. Eur J Surg Oncol 2013;39(10):1071-1078.
19. Curvo-Semedo L, Lambregts DM, Maas M, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 2011;260(3):734-743.
20. Lambregts DM, Rao SX, Sassen S, et al. MRI and diffusion-weighted MRI volumetry for identifcation of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: a bi-institutional validation study. Ann Surg 2015;262(6): 1034-1039.
21. Barbaro B, Vitale R, Valentini V, et al. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neo-adjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012;83(2):594-599.
22. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-and radiation therapy. Radiology 2009;253(1): 116-125.
23. Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology 2011;260(3): 771-780.
24. Kim SH, Lee JY, Lee JM, Han JK, Choi BI. Apparent diffusion coeffcient for evaluating tumour response to neoadjuvant chemora-diation therapy for locally advanced rectal cancer. Eur Radiol 2011;21(5):987-995.
25. Brown G, Richards CJ, Newcombe RG, et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999;211(1):215-222.
26. Le Bihan D. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology 2008;249(3):748-752.
27. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168(2):497-505.
28. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17(6):1471-1474.
29. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preop-erative radiochemotherapy. Int J Colorectal Dis 1997;12(1):19-23.
30. Jung SH, Heo SH, Kim J W, et al. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging 2012;35(1):110-116.
31. Ha HI, Kim AY, Yu CS, Park SH, Ha HK. Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coeffcient for evaluating complete remission after preoperative chemoradiation therapy. Eur Radiol 2013;23(12):3345-3353.
32. Andreou A, Koh DM, Collins DJ, et al. Measurement reproducibility of perfusion fraction and pseudodiffusion coeffcient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol 2013;23(2):428-434.
33. Joo I, Lee JM, Yoon JH, Jang JJ, Han JK, Choi BI. Nonalcoholic fatty liver disease: intravoxel incoherent motion diffusion-weighted MR imaging-an experimental study in a rabbit model. Radiology 2014;270(1):131-140.
34. Woo S, Lee JM, Yoon JH, Joo I, Han JK, Choi BI. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. Radiology 2014;270(3):758-767.
35. Dyvorne HA, Galea N, Nevers T, et al. Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters-a pilot study. Radiology 2013;266(3):920-929.
36. Guiu B, Petit JM, Capitan V, et al. Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. Radiology 2012;265(1):96-103.
37. Kakite S, Dyvorne H, Besa C, et al. Hepato-cellular carcinoma: short-term reproducibil-ity of apparent diffusion coeffcient and intra-voxel incoherent motion parameters at 3.0T. J Magn Reson Imaging 2015;41(1):149-156.
38. Lemke A, Laun FB, Simon D, Stieltjes B, Schad LR. An in vivo verifcation of the intravoxel incoherent motion effect in diffusion-weighted imaging of the abdomen. Magn Reson Med 2010;64(6):1580-1585.
39. Goh V, Halligan S, Gharpuray A, Wellsted D, Sundin J, Bartram CI. Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: infu-ence of tumor region of interest. Radiology 2008;247(3):726-732.
40. Lambregts DM, Beets GL, Maas M, et al. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol 2011; 21(12):2567-2574.
41. Donati OF, Mazaheri Y, Afaq A, et al. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coeffcient. Radiology 2014; 271(1):143-152.
42. Fokas E, Liersch T, Fietkau R, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol 2014;32(15):1554-1562.
43. Valentini V, Minsky BD. Tumor regression grading in rectal cancer: is it time to move forward? J Clin Oncol 2014;32(15):1534-1536.